Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | F2 | P00734 | 3/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 15/20 | 0.37 |
| ▸ | CA1 | P00915 | 14/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | MMP13 | P45452 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4425342 | 1.00 | THRB (0.59) | THRBF2PRSS1PRSS2PRSS3 | |
| SCHEMBL9617176 | 1.00 | THRB (0.59) | THRBF2PRSS1PRSS2PRSS3 | |
| SCHEMBL20561002 | 1.00 | THRB (0.59) | THRBF2PRSS1PRSS2PRSS3 | |
| SCHEMBL31261893 | 1.00 | THRB (0.59) | THRBF2PRSS1PRSS2PRSS3 | |
| SCHEMBL4593915 | 1.00 | THRB (0.59) | THRBF2PRSS1PRSS2PRSS3 | |
| SCHEMBL6740067 | 0.97 | THRB (0.55) | THRBF2PRSS1PRSS2PRSS3 | |
| SCHEMBL1554409 | 0.91 | THRB (0.46) | THRBF2PRSS1PRSS2PRSS3 | |
| SCHEMBL27096212 | 0.91 | THRB (0.46) | THRBF2PRSS1PRSS2PRSS3 | |
| Heptafluorobutyramide SCHEMBL809135 | 0.88 | THRB (0.43) | THRBF2PRSS1PRSS2PRSS3 | |
| SCHEMBL27096224 | 0.88 | THRB (0.41) | THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250152554-A1 | ORALLY ADMINISTRABLE COMPOSITIONS COMPRISING AVOCADO/SOYBEAN UNSAPONIFIABLES AND LIPOIC ACID AND METHODS OF ADMINISTRATION | NUTRAMAX LABORATORIES, INC. (US) | 2025-05-15 | — | — | US | claimed |
| US-12226397-B2 | Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration | NUTRAMAX LABORATORIES, INC. (US) | 2025-02-18 | — | — | US | claimed |
| CN-118813130-B | Coating containing vermiform nano silicon dioxide particles and preparation process thereof | 山东科翰硅源新材料有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-114561072-B | Preparation method of inorganic filler doped modified FEP composite dielectric film | 浙江工业大学 | 2023-07-25 | — | — | CN | claimed |
| CN-116338068-A | Risk grading method for content of PFOS-containing solid waste toxic substances | 沈阳沈化院测试技术有限公司 | 2023-06-27 | — | — | CN | claimed |
| US-20230063903-A1 | METHOD OF SURFACE CHEMICAL FUNCTIONALIZATION FOR DEVELOPING OF FUNCTIONAL HYDROPHOBIC SURFACES | CITY UNIVERSITY OF HONG KONG (HK) | 2023-03-02 | — | — | US | claimed |
| CN-115491089-A | Modified carbon nano tube-fluorocarbon resin and application thereof in wear-resistant aluminum veneer | 山东海天七彩建材有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-114561072-A | Preparation method of inorganic filler doped modified FEP composite dielectric film | 浙江工业大学 | 2022-05-31 | — | — | CN | claimed |
| CN-108440817-B | Hydrophobic and oleophobic polyolefin material and preparation method thereof | 日丰企业集团有限公司 | 2021-03-02 | — | — | CN | claimed |
| CN-106751845-A | A kind of electronic equipment thermal conductivity composite and preparation method thereof | 郑州诚合信息技术有限公司 | 2017-05-31 | — | — | CN | claimed |
| US-20030194378-A1 | Novel aerosol formulation containing a polar fluorinated molecule | ASTRAZENECA AB (SE) | 2003-10-16 | — | — | US | claimed |
| US-3948654-A | PERFLUORO-ORGANIC ACIDS OR ITS SALTS, AMIDES OR ESTERS | XEROX CORPORATION (US) | 1976-04-06 | — | — | US | claimed |
| JP-4025512-A | — | — | None | — | — | JP | disclosed |
| US-20250386434-A9 | FLUORORESIN LONG FILM, METAL-CLAD LAMINATE AND SUBSTRATE FOR CIRCUIT | DAIKIN INDUSTRIES, LTD. (JP) | 2025-12-18 | — | — | US | disclosed |
| EP-4600973-A1 | DIELECTRIC AND METHOD OF MANUFACTURING SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-20250230289-A1 | DIELECTRIC AND METHOD FOR PRODUCING SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2025-07-17 | — | — | US | disclosed |
| US-4292402-A | UNIFORM COATINGS FOR HYDROPHILIC COLLOID LAYERS; ANTISTATIC AGENTS | AGFA-GEVAERT, N.V. (BE) | 1981-09-29 | — | — | US | disclosed |
| US-4235959-A | Photographic matt layers or surfaces | HUYGHEBAERT PAUL ADMINISTRATOR (BE) | 1980-11-25 | — | — | US | disclosed |
| EP-0015592-A1 | Light-sensitive silver halide materials comprising fluorine-containing surfactants | AGFA-GEVAERT N.V. (BE) | 1980-09-17 | — | — | EP | disclosed |
| US-3948654-A | PERFLUORO-ORGANIC ACIDS OR ITS SALTS, AMIDES OR ESTERS | XEROX CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12226397-B2 | Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration | ALOX15B, ALOX15, ALOX12 | THRB 3515/4885F2 138/4885PRSS1 230/4885 |
| US-20250152554-A1 | ORALLY ADMINISTRABLE COMPOSITIONS COMPRISING AVOCADO/SOYBEAN UNSAPONIFIABLES AND LIPOIC ACID AND METHODS OF ADMINISTRATION | ALOX15B, ALOX15, ALOX12 | THRB 3515/4885F2 138/4885PRSS1 230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.